📢New paper out❗️We present the context-of-use of the robust and generalizable Centiloid scale in the clinical routine 🏥 and in the context of DMTs💊. What a timing after the amazing news from last Thursday on Lecanemab!🤓
Academia-EFPIA collaborations were key!
@IMI_AMYPAD
Academia-EFPIA collaborations were key!
@IMI_AMYPAD
🎯@IMI_AMYPAD researchers have published context-of-use recommendations for the implementation of the Centiloid scale in clinical practice.View quoted post on X
@alzdemjournals @IHIEurope @LECollij @MehrnazShekari @FBarkhof @DavidVallez @JuandoGispert
To know more, visit⤵️
amypad.eu/news/recent-ne…